| MR编号 | NL/H/6027/002 |
|---|
| 药品名称 | Sacubitril/Valsartan Synthon 49 mg/51 mg |
|---|
| 活性成分 | - Sacubitril sodium 48.6 mg
- Valsartan 51.4 mg
|
|---|
| 剂型 | Film-coated tablet |
|---|
| 上市许可持有人 | STADA Arzneimittel AG / DE |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) |
|---|
| 互认成员国 - 产品名称 | - Luxembourg (LU)
- Cyprus (CY)
SACUBITRIL+VALSARTAN/STADA 49 mg/51 mg film-coated tablets - Iceland (IS)
- Romania (RO)
Sacubitril Valsartan STADA 49mg/51mg comprimate filmate - Ireland (IE)
- Slovakia (SK)
Sacubitril/Valsartan STADA 49 mg/51 mg - Austria (AT)
- Slovenia (SI)
- France (FR)
- Malta (MT)
Sacubitril/Valsartan Clonmel Tablet, film coated 49mg/51mg - Spain (ES)
- Portugal (PT)
- Greece (GR)
- Sweden (SE)
- Germany (DE)
Sacubitril/Valsartan AL 49 mg/51 mg Filmtabletten - Norway (NO)
- Denmark (DK)
Sacubitril/Valsartan Stada - Finland (FI)
- Belgium (BE)
- Hungary (HU)
|
|---|
| 许可日期 | 2025/06/20 |
|---|
| 最近更新日期 | 2025/06/21 |
|---|
| 药物ATC编码 | - C09DX04 valsartan and sacubitril
| 申请类型 | - TypeLevel1：Known Active Substance
- TypeLevel2：Additional Strength/Form
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|